Hess Corporation has been in the spotlight with various market actions being reported. Notably,
Chevron purchased around 5% of Hess's stock, confidently voicing its merger intentions. Numerous investment entities such as Laurion Capital Management, Wells Fargo, and Arrowstreet Capital have purchased substantial Hess shares, underscoring potential growth prospects. Regulatory approval appears to be nearing as Hess announces HSR Clearance of the Chevron-Hess Merger. Furthermore, notable financial entities like UBS and TD Cowen adjusted their price targets for Hess, reflecting anticipation of upcoming Q1 earnings. Similarly, Hess has deepened its healthcare initiative in Guyana, signaling a push towards social responsibility. Strikingly, Hess is also a significant figure in various portfolios such as Citadel Investment Group, Adage Capital Management, and Ken Griffin’s, demonstrating an encouraging confidence in the firm's potential. Despite regulatory hurdles, Hess reported strong Q4 2024 earnings and surpassed estimates, providing a positive outlook for investors.
Hess Corporation HES News Analytics from Mon, 30 Sep 2024 07:00:00 GMT to Sat, 19 Apr 2025 17:29:00 GMT -
Rating 6
- Innovation 5
- Information 8
- Rumor -1
